
Long-Acting GHRH Analog with Drug Affinity Complex
CJC-1295 with DAC is a modified GHRH analog conjugated to a Drug Affinity Complex for extended half-life. Biolyn supplies research-grade CJC-1295 DAC for endocrine research and B2B partners.
Modified GRF(1-29) with amino acid substitutions (Ala2, Gln8, Ala15, Leu27) conjugated to a reactive Drug Affinity Complex (DAC) that binds serum albumin in vivo, extending half-life to ~8 days.